Target intelligence / Profile preview

Serine protease 51 (PRSS51)

Target
PRSS51
Molecular classification
Enzyme, Serine protease family
01

Overview

Serine protease 51 (PRSS51) is a predicted serine-type endopeptidase encoded on human chromosome 8. It shares homology with other testis-enriched serine proteases, particularly PRSS55; however, functional knockout studies in mice demonstrated that loss of Prss51 does not impair fertility or essential reproductive functions. PRSS51 is expressed at highest levels in the testis and liver, and is thought to reside in extracellular compartments. While its sequence conservation across mammals suggests evolutionary pressure, definitive biological roles—especially in human physiology or pathology—remain to be clarified. No compelling evidence supports its involvement in disease or its potential as a pharmacological target[1][2][3][4]. Key caveats: PRSS51 is frequently studied alongside PRSS55, which is critical for mouse sperm maturation, but PRSS51 itself appears dispensable for fertility and no non-redundant phenotype has been established in knockout models[1]. There is no evidence that PRSS51 currently qualifies as a valid drug target or disease biomarker, nor is there significant human disease implication based on available omics and pathway annotations[2][3].

Other names
protease, serine, 51Serine protease-like protein 51PRSS51protease, serine 51
02

Mechanism of action

Not applicable; there are no characterized drug mechanisms for PRSS51.

03

Biological functions

Predicted proteolysis (protein cleavage)Serine-type endopeptidase activityMay participate in extracellular proteolytic pathways
04

Disease associations

None established. No direct link to major human diseases (e.g., cancer, infection, neurodegeneration) as of current research
05

Safety considerations

None specifically known. Therapeutic or experimental modulation of PRSS51 is not documented, so safety profile remains unexplored.
06

Interacting drugs

None reported. No drugs or small molecules are known to act upon or target PRSS51
07

Biomarkers

None validated. PRSS51 is not used as a biomarker for disease diagnosis, prognosis, or therapeutic monitoring

Beyond the preview

Go deeper on Serine protease 51 (PRSS51).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine protease 51 (PRSS51).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call